Find policies, billing codes, payers, states, and providers
Intraoral Prostheses
Customize your policy alerts
Sign up for Cigna Policy 0584 alerts
Get alerted when Policy 0584 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity and coding guidance for reconstructive intraoral prostheses (e.g., obturators, palatal augmentation, mandibular resection prostheses) for Cigna-administered health benefit plans when coverage is available under a member's benefit document.
Revised statements regarding referring to benefit plan language.
Added clarifying verbiage regarding congenital defects (e.g., cleft palate).
Revised policy statements regarding cancer to include both malignant or benign tumors/lesions.
Coverage Criteria for Reconstructive Intraoral Prostheses
Reconstructive Intraoral Prostheses — Maxillary and Mandibular Resection Prostheses
Maxillary prostheses (CPT 21079, 21080) and mandibular resection prostheses (CPT 21081, 21082) are medically necessary when ANY of the following criteria are met:
Chewing injuries are not considered accidental injuries.
Reconstructive indications (any one of the following)
- i. Removal of a tumor.
- ii. A cancer-related episode of care that results in reconstruction.
Reconstructive Intraoral Prostheses — Covered Indications
Covered when prosthetic rehabilitation is used to restore separation between oral and nasal cavities and/or to support speech, swallowing, mastication, or facial form as part of reconstruction for congenital, developmental, traumatic, or acquired defects, including tumor resection.
Supported by AAOMS, ACPA, ACP, and ASHA guidance.
Staged or multiple prostheses may be clinically necessary for complex defects; interdisciplinary care recommended.
Other Indications — Limited Evidence
Not routinely covered; benefit is uncertain where evidence is limited.
May be considered experimental, investigational, or not medically necessary depending on the member's benefit plan language.
Intraoral prostheses are not medically necessary for any indication other than the reconstructive uses described in this policy. This exclusion includes, but is not limited to, use for individuals who have lost teeth from non‑cancer related decay or when the device is used in conjunction with non‑covered dental implants.
Proposals to use intraoral prosthetic devices for neurologic conditions (for example, cerebrovascular disease or stroke), neuromuscular disorders, or to treat dysphagia or dysarthria lack robust evidence. The peer‑reviewed literature is limited to small observational studies and case reports, and there are no clinical practice guideline recommendations from major U.S. professional societies supporting routine use for these indications.
Any indication that is not expressly listed in the reconstructive criteria is considered excluded from coverage. Specifically, tooth loss resulting from non‑cancer decay and uses paired with non‑covered dental implants are examples of indications that are not medically necessary under this policy.
Routine use of intraoral prosthetic devices for neurologic conditions or for other dental indications that are not included in the reconstructive criteria is not supported by major professional society guidelines and is based on limited evidence; such uses may be considered investigational or not medically necessary depending on the member's benefit language.
Coding and Billing Guidance
| affected codes | See benefit plan and policy-specific coding section for exact CPT/HCPCS codes; this document references code-level review and provider referral to benefit language. |
Provider Actions, Prior Authorization, and Documentation
Plan-dependent coverage — verify benefit plan for prior authorization
Coverage for intraoral prostheses varies by plan; providers must refer to the customer's benefit plan document to determine whether prior authorization or coverage applies for the CPT codes referenced in this policy.
- Check the member’s specific benefit plan document (e.g., Group Service Agreement, Evidence of Coverage, SPD) for any plan-level exclusions or authorization requirements.
- In the event of a conflict between this Coverage Policy and the member’s benefit plan document, the benefit plan document controls.
Refer to benefit plan for prior authorization — check updated plan language
This policy was revised on annual review; providers should confirm current prior authorization requirements and any code-level rules in the member’s benefit plan language rather than relying solely on this policy summary.
- Annual review revised statements regarding referring to benefit plan language; check plan language for any changes to prior authorization procedures or affected codes.
Step therapy — not specified in this policy
Step therapy requirements are not specified in this Coverage Policy.
- If a plan imposes step therapy, providers must follow the specific procedures in the member’s benefit plan document.
Staged prosthetic care — document staged treatment plans and rationale
Staged or multiple prostheses may be clinically indicated for complex maxillofacial defects; documentation should describe the staged treatment plan and the clinical rationale for multiple or sequential prostheses.
- Record therapeutic goals for each stage (e.g., interim vs definitive prosthesis) and how each device contributes to restoration of mastication, deglutition, speech, or anatomic separation.
- Include interdisciplinary recommendations that support staged care (e.g., coordination with surgery, orthodontics, speech-language pathology).
Coding and billing documentation — use current, effective codes
When submitting claims, use the most appropriate and effective codes at the date of service; deleted or non‑effective codes at the time of service may not be eligible for reimbursement.
Required clinical justification and interdisciplinary plan — document defect, goals, and team care
Clinical documentation must justify use of intraoral prosthesis for reconstruction of congenital, developmental, or acquired defects and include an interdisciplinary care plan and specified functional goals.
- Document defect etiology and anatomic site (maxilla, mandible, soft palate, composite resections or traumatic injury).
- State therapeutic goals (e.g., restoration of mastication, deglutition, speech, re-establishment of anatomic barriers) and whether prosthetic rehabilitation is primary or adjunctive to surgery.
- Include an interdisciplinary plan (e.g., prosthodontics, oral/maxillofacial surgery, orthodontics, speech-language pathology) and timing for interim versus definitive prostheses.
Coding compliance required — missing covered codes causes denial
Claims submitted without covered code(s) under the applicable Coverage Policy will be denied as not covered; ensure submitted codes match covered codes and plan language.
- Confirm that billed procedure codes correspond to codes listed as covered when criteria are met; otherwise the claim is subject to denial.
- If plan language differs from this policy for covered codes, follow the member’s benefit plan document.
Limited evidence — denial risk for neurologic and other non‑covered indications
Use of intraoral prosthetic devices for neurologic indications (e.g., stroke, neuromuscular disorders) and other non‑dental indications is supported by limited evidence and may trigger coverage denial when presented as routine therapy.
- Major U.S. specialty guidelines (e.g., AHA/ASA, AAN) do not include intraoral prostheses in routine management for dysphagia or dysarthria related to neurologic conditions; document strong clinical justification if pursuing coverage.
- These indications may be considered investigational or not medically necessary depending on the member’s benefit plan.
Definitions
Background
Intraoral prostheses are devices designed to replace missing portions of the oral and craniofacial structures — including bone, teeth, or soft tissue — to restore or optimize function. They are used to re‑establish separation between oral and nasal cavities, support speech and swallowing, restore mastication, and assist with facial form following congenital, developmental, traumatic, or acquired defects. Care is typically multidisciplinary and may include interim and definitive prostheses, either as primary treatment or adjunctive to surgical reconstruction.
Revision History
Annual review: revised statements referring providers to benefit plan language; added clarifying verbiage regarding congenital defects (e.g., cleft palate); and revised cancer-related policy language to include both malignant and benign tumors/lesions.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.